[ad_1]

This study highlights how important it is to keep an eye on women who’ve had abnormal cells in their cervix. In the UK, these women have follow-up screening tests and tests for the HPV infections that cause cervical cancer, to reduce the risk of the abnormal cells coming back.”Robert Music, chief executive of Jo’s Cervical Cancer Trust, said the study highlighted a need to look at the follow-up treatment of women with CIN3.Meanwhile, women over 50 are being urged to have regular smear tests after separate research studies by Cancer Research UK indicated that those who did not attend were six times more likely to develop cervical cancer than those whose test results were normal.In England and Northern Ireland women aged 25 to 49 are offered screening every three years, and every five years between 50 and 64.Julietta Patnick, director of the NHS Cancer Screening Programmes, said women could control their risk of cervical cancer through regular screening.”Any abnormalities that might be found can then be treated in order that they do not go on to develop into cancer. Where a cervical cancer is found through screening it is usually at a very early stage where treatment has a greater chance of success. It is essential that women are aware of this when deciding whether or not to be screened.”CancerCervical cancerCancerMedical researchHealthWomenDenis Campbelltheguardian.com © 2014 Guardian News and Media Limited or its affiliated companies. All rights reserved. …

Source: Guardian Unlimited ScienceCategory: Science Authors: Tags: The Guardian Cervical cancer News Health Medical research Society Women UK news Source Type: news

Related Links:

Objectives
American Brachytherapy Society (ABS)-recommended interstitial brachytherapy (IBT) should be considered for bulky vaginal tumor thicker than 5 mm. The aim of this study was to evaluate the ABS consensus guideline for patients with severe vaginal invasion based on our long-term follow-up results.
Methods/Materials
The study included 7 patients with vaginal cancer and 14 patients with cervical cancer invading to the lower vagina. Based on prebrachytherapy magnetic resonance imaging findings, patients received intracavitary brachytherapy (ICT) for vaginal tumors 5 mm or less or IBT for vaginal tumors less than …

Conditions:   Human Papillomavirus-Related Carcinoma;   Human Papillomavirus-Related Cervical Carcinoma;   Stage IB2 Cervical Cancer AJCC v8;   Stage II Cervical Cancer AJCC v8;   Stage II Vaginal Cancer AJCC v8;   Stage IIA Cervical Cancer AJCC v8;   Stage IIA Vaginal Cancer  AJCC v8;   Stage IIA1 Cervical Cancer AJCC v8;   Stage IIA2 Cervical Cancer AJCC v8;   Stage IIB&…

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

ConclusionExtraperitoneal para-aortic lymphadenectomy by robot-assisted laparoscopy provides good visualization of the operative field without arm conflict. Still, perforation of the peritoneum and symptomatic lymphocysts are a postoperative concern.

ConclusionsAbout 1 of 4 patients (25%) with single gynecologic cancer recurrence needs IOUS to benefit from MIS for complete secondary cytoreduction.

This study evaluates a novel technique of laparoscopic ovarian transposition performed by Gynecologic Oncologists prior to pelvic radiation for gynecologic cancer. A retrospective review was completed of all patients that underwent laparoscopic ovarian transposition from February 2007 to June 2017 at one tertiary care cancer. The technique involves salpingectomy, followed by retroperitoneal dissection to move the ovaries lateral to the hepatic and splenic flexures of the colon. Normal ovarian function was defined by the absence of vasomotor symptoms, FSH and menstrual history (if menstruating). The radiation dose to the ov…

ConclusionExtraperitoneal para-aortic lymphadenectomy by robot-assisted laparoscopy provides good visualization of the operative field without arm conflict. Still, perforation of the peritoneum and symptomatic lymphocysts are a postoperative concern.

ConclusionsAbout 1 of 4 patients (25%) with single gynecologic cancer recurrence needs IOUS to benefit from MIS for complete secondary cytoreduction.

This study evaluates a novel technique of laparoscopic ovarian transposition performed by Gynecologic Oncologists prior to pelvic radiation for gynecologic cancer. A retrospective review was completed of all patients that underwent laparoscopic ovarian transposition from February 2007 to June 2017 at one tertiary care cancer. The technique involves salpingectomy, followed by retroperitoneal dissection to move the ovaries lateral to the hepatic and splenic flexures of the colon. Normal ovarian function was defined by the absence of vasomotor symptoms, FSH and menstrual history (if menstruating). The radiation dose to the ov…

Conclusion Extraperitoneal para-aortic lymphadenectomy by robot-assisted laparoscopy provides good visualization of the operative field without arm conflict. Still, perforation of the peritoneum and symptomatic lymphocysts are a postoperative concern.

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here